Shire, the London-listed pharmaceuticals group, has moved to bolster its rare disease treatment business with the $4.2bn acquisition of ViroPharma. Ireland-domiciled Shire will pay $50 a share in cash ...
Glenn Tillotson is a full-time employee of ViroPharma Incorporated, PA, USA. Alan Tice has received income for research and consulting from Replidyne, Pfizer and Astellas. This work has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback